Quality of Life in Multiple Sclerosis Compared to Amyotrophic Lateral Sclerosis: Fatigue and Fast Disease Progression Interferes with the Ability to Psychosocially Adjust
Authors:
- Luisa T. BalzLuisa T. Balz
- Ingo UttnerIUIngo Uttner
- Jochen WeishauptJWJochen Weishaupt
- Albert C. LudolphALAlbert C. Ludolph
- Daniela TaranuDTDaniela Taranu
- Ioannis VardakasIVIoannis Vardakas
- Stefanie JungSJStefanie Jung
- Tanja FangerauTFTanja Fangerau
- Deborah K. ErhartDEDeborah K. Erhart
- Makbule SenelMSMakbule Senel
- Hayrettin TumaniHTHayrettin Tumani
- Dorothée E. LuléDLDorothée E. Lulé
Open Access
- 11 July 2025
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 15 (7) , 745
Abstract
Background/Objectives: Multiple sclerosis (MS) is a complex neurological disease that is associated with a broad spectrum of physical and psychological symptoms. Psychosocial adjustment (PSA) refers to the ability to cope with these challenges, which influence quality of life (QoL) and depressiveness in ways not yet fully understood. This study explores the relationship of PSA and disease-specific symptoms in MS, including fatigue, a prominent MS symptom. Additionally, PSA was compared to Amyotrophic Lateral Sclerosis (ALS) to disentangle the impact of disease trajectory on PSA. Methods: We interviewed 77 MS patients using patient-reported outcome measures on QoL and depression and compared them to 30 ALS patients. Confirmatory factor analysis and regression analysis were used to identify PSA indicators and predictors in MS, while t-tests assessed PSA differences across diseases. Results: Key PSA indicators in MS included physical (PQoL), mental (MQoL), and subjective (SQoL) quality of life, as well as depressiveness, with cognitive and motor fatigue emerging as significant predictors. MS patients had higher PQoL and SQoL and lower levels of depression compared to ALS patients, while both groups were comparable with regard to MQoL. Conclusions: PSA in MS is supported by high QoL and low depression levels, with fatigue being a significant predictor. Despite different disease trajectories, patients with MS and ALS showed comparable MQoL, indicating that both diseases similarly impact mental QoL, reflecting a partial overlap in psychosocial adjustment. Overall, psychosocial adjustment was more favorable in MS, likely due to its slower disease progression compared to ALS.Keywords
This publication has 67 references indexed in Scilit:
- A systematic review and meta-analysis exploring the efficacy of mindfulness-based interventions on quality of life in people with multiple sclerosisJournal of Neurology, 2022
- Social support is linked to mental health, quality of life, and motor function in multiple sclerosisJournal of Neurology, 2021
- Disease progression but not physical state per se determines mental wellbeing in ALSJournal of Neurology, 2020
- Changes in disability in people with multiple sclerosis: a 10-year prospective studyJournal of Neurology, 2017
- Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilienceQuality of Life Research, 2016
- Evaluation of an Expanded Disability Status Scale (EDSS) modeling strategy in multiple sclerosisMedical & Biological Engineering & Computing, 2015
- Emotional adjustment in amyotrophic lateral sclerosis (ALS)Journal of Neurology, 2011
- The Potential of Anamnestic Comparative Self-Assessment (ACSA) to Reduce Bias in the Measurement of Subjective Well-BeingJournal of Happiness Studies, 2006
- Health-related Quality of Life in Multiple Sclerosis: The Impact of Disability, Gender and Employment StatusQuality of Life Research, 2006
- Psychiatric manifestations of autoimmune disordersCurrent Treatment Options in Neurology, 2005